4//SEC Filing
Okazaki Jason A 4
Accession 0000950170-24-051244
CIK 0001426800other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:05 PM ET
Size
7.3 KB
Accession
0000950170-24-051244
Insider Transaction Report
Form 4
Okazaki Jason A
DirectorCEO and President
Transactions
- Award
Common Stock
2024-04-29+4,166→ 17,992 total - Sale
Common Stock
2024-04-30$12.71/sh−1,569$19,937→ 16,423 total
Footnotes (3)
- [F1]Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved.
- [F2]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.3851 to $12.8847, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
Documents
Issuer
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Entity typeother
Related Parties
1- filerCIK 0001807214
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:05 PM ET
- Size
- 7.3 KB